Literature DB >> 3084712

Valproate causes metabolic disturbance in normal man.

D M Turnbull, D J Dick, L Wilson, H S Sherratt, K G Alberti.   

Abstract

Valproate is an important anticonvulsant which is rarely associated with fatal hepatotoxicity. Previous experiments have shown that valproate inhibits several metabolic processes in isolated rat hepatocytes and when administered to starved rats causes a fall in the blood concentrations of glucose and ketone bodies. Since these changes may be related to the hepatotoxicity, the effect of valproate administration on intermediary metabolism in man was studied. One gram of valproate given orally to fasted normal humans caused a 78% fall in the concentration of 3-hydroxybutyrate and a 60% fall in total ketones. Also the concentrations of lactate, pyruvate, alanine and glycerol increased after valproate administration. Similar changes were observed after intravenous administration of 400 mg of valproate. Valproate clearly has a significant effect on intermediary metabolism in the liver and this is probably related to the mechanism of the hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084712      PMCID: PMC1028766          DOI: 10.1136/jnnp.49.4.405

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  8 in total

1.  Enzymic determination of D(-)-beta-hydroxybutyric acid and acetoacetic acid in blood.

Authors:  D H WILLIAMSON; J MELLANBY; H A KREBS
Journal:  Biochem J       Date:  1962-01       Impact factor: 3.857

2.  A simple and ultrasensitive method for determination of free fatty acid by radiochemical assay.

Authors:  R J Ho; H C Meng
Journal:  Anal Biochem       Date:  1969-10-01       Impact factor: 3.365

3.  The occurrence of C6--C10-dicarboxylic acids in urine from patients and rats treated with dipropylacetate.

Authors:  P B Mortensen; N Gregersen; S Kølvraa; E Christensen
Journal:  Biochem Med       Date:  1980-10

4.  Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate.

Authors:  B Lloyd; J Burrin; P Smythe; K G Alberti
Journal:  Clin Chem       Date:  1978-10       Impact factor: 8.327

5.  The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats.

Authors:  D M Turnbull; A J Bone; K Bartlett; P P Koundakjian; H S Sherratt
Journal:  Biochem Pharmacol       Date:  1983-06-15       Impact factor: 5.858

6.  Chronic valproate administration reduces fasting ketonemia in children.

Authors:  J H Thurston; J E Carroll; W E Dodson; R E Hauhart; V Tasch
Journal:  Neurology       Date:  1983-10       Impact factor: 9.910

7.  Dopamine blockade inhibits starvation ketosis in man.

Authors:  D G Johnston; G Blesa-Malpica; J M Burrin; C Waugh; D Cook; H Orskov; K G Alberti
Journal:  Clin Endocrinol (Oxf)       Date:  1983-09       Impact factor: 3.478

8.  Influence of valproic acid on hepatic carbohydrate and lipid metabolism.

Authors:  C M Becker; R A Harris
Journal:  Arch Biochem Biophys       Date:  1983-06       Impact factor: 4.013

  8 in total
  11 in total

1.  Valproic acid-associated encephalopathy.

Authors:  G L Jones; F Matsuo; J R Baringer; W H Reichert
Journal:  West J Med       Date:  1990-08

Review 2.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

3.  Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions.

Authors:  A S Luder; J K Parks; F Frerman; W D Parker
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Hyperaminoacidemia in epileptic children treated with valproic acid.

Authors:  M Castro-Gago; E Rodrigo-Saez; I Novo-Rodriguez; M F Camiña; S Rodriguez-Segade
Journal:  Childs Nerv Syst       Date:  1990-12       Impact factor: 1.475

5.  Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin.

Authors:  Anton Terasmaa; Ursel Soomets; Julia Oflijan; Marite Punapart; Mats Hansen; Vallo Matto; Kersti Ehrlich; Anne Must; Sulev Kõks; Eero Vasar
Journal:  J Physiol Biochem       Date:  2011-04-02       Impact factor: 4.158

Review 6.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

7.  Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid.

Authors:  K Iinuma; K Hayasaka; K Narisawa; K Tada; K Hori
Journal:  Eur J Pediatr       Date:  1988-12       Impact factor: 3.183

Review 8.  Valproate hepatotoxicity syndrome: hypotheses of pathogenesis.

Authors:  J R Stephens; R H Levy
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

9.  Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity.

Authors:  S Krähenbühl; G Mang; H Kupferschmidt; P J Meier; M Krause
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

10.  The metabolic effects of aspirin in fasting and fed subjects: relevance to the aetiology of Reye's syndrome.

Authors:  F M Williams; R E Ferner; M Graham; P G Blain; K G Alberti; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.